CVS Health (NYSE:CVS) Stock Rating Lowered by Wall Street Zen

CVS Health (NYSE:CVS) was downgraded by equities research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued on Saturday.

Several other research analysts also recently weighed in on the stock. Royal Bank Of Canada upped their target price on shares of CVS Health from $81.00 to $93.00 and gave the stock an “outperform” rating in a report on Thursday. Zacks Research downgraded shares of CVS Health from a “strong-buy” rating to a “hold” rating in a report on Monday, September 8th. Sanford C. Bernstein upped their target price on shares of CVS Health from $72.00 to $77.00 and gave the stock a “market perform” rating in a report on Friday, September 5th. Barclays boosted their price target on shares of CVS Health from $80.00 to $87.00 and gave the stock an “overweight” rating in a research note on Thursday, September 4th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of CVS Health in a research note on Tuesday, October 14th. Two research analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $87.91.

CVS Health Trading Up 1.9%

Shares of CVS stock opened at $78.13 on Friday. The company has a market cap of $99.18 billion, a price-to-earnings ratio of 205.61, a PEG ratio of 0.87 and a beta of 0.60. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.62. The firm has a fifty day moving average price of $76.49 and a 200-day moving average price of $69.04. CVS Health has a 1 year low of $43.56 and a 1 year high of $85.15.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.24. The company had revenue of $102.87 billion during the quarter, compared to the consensus estimate of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. CVS Health’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.09 EPS. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, equities analysts predict that CVS Health will post 5.89 earnings per share for the current year.

Insider Activity

In other news, Director Anne A. Finucane sold 7,500 shares of the company’s stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total transaction of $532,650.00. Following the sale, the director directly owned 22,156 shares in the company, valued at approximately $1,573,519.12. This represents a 25.29% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.22% of the company’s stock.

Institutional Trading of CVS Health

Hedge funds have recently made changes to their positions in the business. Avion Wealth raised its position in shares of CVS Health by 99.0% during the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after buying an additional 189 shares in the last quarter. Harbor Capital Advisors Inc. raised its position in CVS Health by 72.1% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 142 shares during the period. Corundum Trust Company INC purchased a new stake in CVS Health in the 3rd quarter worth about $29,000. Harbor Asset Planning Inc. purchased a new stake in CVS Health in the 2nd quarter worth about $30,000. Finally, Bell Investment Advisors Inc raised its position in CVS Health by 119.8% in the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 248 shares during the period. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.